The Protein Folding Revolution: How AlphaFold Changed Biology Forever

The 50-Year Grand Challenge

For half a century, predicting how a protein’s amino acid sequence folds into its three-dimensional structure was one of biology’s most important unsolved problems. A protein’s shape determines its function, and understanding that shape is essential for drug design, disease research, and bioengineering. Experimental methods like X-ray crystallography and cryo-electron microscopy could determine protein structures, but each one took months to years and cost hundreds of thousands of dollars. Then, in 2020, DeepMind’s AlphaFold effectively solved the problem.

AlphaFold’s Impact on Research

AlphaFold and its successors have predicted structures for virtually every known protein — over 200 million structures released in a public database that has been accessed by over 2 million researchers in 190 countries. This resource has accelerated research timelines from years to days across fields including drug discovery, enzyme engineering, crop science, and materials development. Within two years of AlphaFold’s release, researchers had already used its predictions to identify potential drug targets for malaria, design more effective vaccines, and engineer enzymes that break down plastic waste.

Drug Discovery Applications

Pharmaceutical companies have integrated protein structure prediction into their drug discovery pipelines with transformative results. Understanding the precise three-dimensional shape of drug target proteins enables computational screening of millions of potential drug molecules, identifying candidates that fit the target like a key in a lock. This approach has accelerated early-stage drug discovery by 3-5 times and reduced the failure rate of drug candidates entering clinical trials. Several drugs designed with AI-predicted protein structures entered clinical trials in 2025.

Beyond Structure Prediction

The field has advanced beyond static structure prediction to modeling protein dynamics, protein-protein interactions, and the design of entirely novel proteins that do not exist in nature. David Baker’s lab at the University of Washington, building on structural prediction advances, has designed proteins that function as biosensors, targeted therapeutics, and industrial catalysts. The 2024 Nobel Prize in Chemistry, awarded to the creators of AlphaFold and computational protein design tools, recognized this work as one of the most significant scientific achievements of the century.